Cantor Fitzgerald Reiterates Overweight on Enovix, Maintains $25 Price Target
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsReiterationPrice Target
Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $25 price target.
Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $25 price target.